Bronte Capital Management Pty »

An2 Therapeutics shares owned by Bronte Capital Management Pty

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Bronte Capital Management Pty from 13F filings

Historical chart of Bronte Capital Management Pty investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Bronte Capital Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Bronte Capital Management Pty

Quarter filed Position value Share count Share price at filing
2026-06-30 $53k 11k 4.84